The genetic association of coronavirus disease 2019 (COVID‐19) with its complications has not been fully understood. This study aimed to identify variants and haplotypes of candidate genes implicated in COVID‐19… Click to show full abstract
The genetic association of coronavirus disease 2019 (COVID‐19) with its complications has not been fully understood. This study aimed to identify variants and haplotypes of candidate genes implicated in COVID‐19 related traits by combining the literature review and pathway analysis. To explore such genes, the protein‐protein interactions and relevant pathways of COVID‐19‐associated genes were assessed. A number of variants on candidate genes were identified from Genome‐wide association studies (GWASs) which were associated with COVID‐19 related traits (p ˂ 10‐6). Haplotypic blocks were assessed using haplotypic structures among the 1000 Genomes Project (r2 ≥ 0.8, D′ ≥ 0.8). Further functional analyses were performed on the selected variants. The results demonstrated that a group of variants in ACE and AGT genes were significantly correlated with COVID‐19 related traits. Three haplotypes were identified to be involved in the blood metabolites levels and the development of blood pressure. Functional analyses revealed that most GWAS index variants were expression quantitative trait loci and had transcription factor binding sites, exonic splicing enhancers or silencer activities. Furthermore, the proxy haplotype variants, rs4316, rs4353, rs4359, and three variants, namely rs2493133, rs2478543, and rs5051, were associated with blood metabolite and systolic blood pressure, respectively. These variants exerted more regulatory effects compared with other GWAS variants. The present study indicates that the genetic variants and candidate haplotypes of COVID‐19 related genes are associated with blood pressure and blood metabolites. However, further observational studies are warranted to confirm these results.
               
Click one of the above tabs to view related content.